• Molecular NameEnprofylline
  • Synonym3-n-Propylxanthine; 3-Propylxanthine; Enprofilina [INN-Spanish]; Enprofyllinum [INN-Latin]
  • Weight194.194
  • Drugbank_IDDB00824
  • ACS_NON/A
  • Show 2D model
  • LogP (experiment)0.33
  • LogP (predicted, AB/LogP v2.0)0.23
  • pkaN/A
  • LogD (pH=7, predicted)0.2
  • Solubility (experiment)1.2 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-2.88
  • LogSw (predicted, AB/LogsW2.0)2.78
  • Sw (mg/ml) (predicted, ACD/Labs)0.26
  • No.of HBond Donors2
  • No.of HBond Acceptors6
  • No.of Rotatable Bonds2
  • TPSA78.09
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyN/A
  • Absorption_valueN/A
  • Absorption (description)Rapidly absorbed from the digestive tract
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding49.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life1.9 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A